HMC showcases world-class dermatology services in ‘Your Health, Our Priority' drive
Hanane Djoua
Doha
As part of its ongoing Your Health, Our Priority campaign, Hamad Medical Corporation (HMC) has spotlighted its Dermatology and Venereology Department — a regional hub of excellence in skin health that continues to gain global recognition for innovation, research, and specialised care.
HMC's Dermatology Department delivers high-quality, personalised treatment for patients of all ages and conditions — ranging from eczema, psoriasis, vitiligo, and alopecia to skin cancer, rare genetic disorders, and complex autoimmune diseases.
The department also stands at the forefront of technological advancement and multidisciplinary research in dermatology.
'Our dermatology services reflect HMC's broader commitment to delivering specialised, world-class healthcare to the community of Qatar,' said Prof Martin Steinhoff, chairman of HMC's Dermatology and Venereology Department.
Ranked among the top two percent of researchers worldwide by Stanford University, Prof Steinhoff emphasised the department's capacity to address both common and rare skin disorders with the most updated and tailored therapies.
In an interview with Qatar Tribune, Prof Steinhoff said, 'Our department is the largest of its kind in Qatar and among the most advanced in the region. With over 14 sub-specialty clinics, we see more than 300 patients a day and cover the full spectrum of dermatologic services — from medical and surgical dermatology to advanced therapies for genetic and autoimmune skin diseases.'
Among the key services offered are:
• Biologic and immunomodulatory therapies for inflammatory skin diseases;
• Advanced laser treatments for pigmentation, scarring, and rosacea;
• Dermato-surgery for skin biopsies and cancer excisions;
• Hair and scalp clinics for alopecia and related disorders;
• Light-based therapies for conditions such as cutaneous T-cell lymphoma;
• Paediatric and geriatric dermatology clinics — the latter being one of the first worldwide;
• Genetic dermatology for rare genodermatoses and haemangiomas;
• Sclerotherapy and foam sclerotherapy for varicose and spider veins.
'The integration of real-time skin imaging, dermoscopy, and ultrasound in our diagnostics enables earlier, more precise detection of life-threatening conditions like melanoma and scleroderma,' Dr Steinhoff noted, adding that emergency care for severe skin conditions such as Stevens-Johnson Syndrome, drug allergies, and erythroderma is also part of their specialty.
Commenting on the department's international vision, he shared, 'We are now developing aesthetic dermatology as a future service and are consistently adopting the latest minimally invasive treatments and biologic medications. Our mission is to bring the same level of care that patients would receive in leading centres like New York or Berlin — right here in Qatar.'
Prof Steinhoff also revealed that the Dermatology Department offers an American-accredited residency program, ensuring that Qatari-trained dermatologists receive an education aligned with international standards.
'From day one, our residents follow a rigorous curriculum equivalent to what they would experience in the US or Germany. We host educational workshops, collaborate with global experts, and constantly bring international knowledge into Qatar,' he said.
Dr Ayda Al Hammadi, senior consultant at the department, echoed this vision, saying, 'Our goal is not only to treat but to set new global standards in dermatological care.'
Dr Sara Al Khawaga, specialist in dermatology, emphasised the blend of compassionate care and scientific progress, noting, 'We ensure every patient receives the most effective, evidence-based treatment.'
Dr Aysha Al Malki, director of the Dermatology Residency Programme, said: 'Our strength lies in combining research, education, and clinical excellence. Through this, we continue to build a future-ready, world-class dermatology service in Qatar.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Qatar Tribune
3 hours ago
- Qatar Tribune
WHO honours HMC's Tobacco Control Center with 2025 World No Tobacco Day Award
DOHA: The World Health Organization (WHO) has recognized Hamad Medical Corporation's (HMC) Tobacco Control Center with the 2025 World No Tobacco Day Award. The award recognizes the Center's significant efforts in reducing tobacco use and helping the public in Qatar and the Eastern Mediterranean region to quit all forms of tobacco use. HMC's Tobacco Control Center, which has been a WHO Collaborating Center since 2017, was selected as one of the award recipients in the Eastern Mediterranean region. This marks the second time the Center has received the award, having first been honored in 2021. The award was presented by WHO Representative in Qatar Dr Rayana Bou Haka, in the presence of HMC's Deputy Chief Medical Officer for Medical Services and Chairman of the Department of Medicine Dr. Ahmed Al Mohammed. Director of HMC's Tobacco Control Center Dr Ahmad Mohamed Al Mulla, expressed his pride in the Center receiving the award for the second time. He praised the dedication of the Center's team and the achievements in tobacco control in Qatar and the Eastern Mediterranean region. He said: "This recognition by WHO reflects the positive outcomes of the hard work carried out by the Center's team and its impact on many tobacco users in our community." In turn Dr Rayana Bou Haka also commended the Center's local and regional activities and said the award was well-deserved. She thanked the Center's staff for their continued efforts in tobacco control in Qatar and the region and emphasized the importance of continued collaboration between the Center and WHO, given the significant value of its tobacco control programs. The Tobacco Control Center organizes educational and awareness initiatives targeting school and university students, as well as employees in ministries and public institutions. The Center also delivers training programs for healthcare professionals and community organizations in Qatar and across the Eastern Mediterranean. In addition, it provides smoking cessation services and conducts research in the field of tobacco cessation. WHO annually recognizes individuals and institutions from each of its six regions on the occasion of World No Tobacco Day for their outstanding contributions to tobacco control. The recognition includes honorary awards, special certificates of appreciation from the WHO Director-General, and awards specifically related to World No Tobacco Day.
Qatar Tribune
13 hours ago
- Qatar Tribune
WHO honours HMC's Tobacco Control Centre with 2025 World No Tobacco Day Award
Tribune News Network Doha The World Health Organization (WHO) has recognised Hamad Medical Corporation's (HMC) Tobacco Control Centre with the 2025 World No Tobacco Day Award. The award recognises the Centre's significant efforts in reducing tobacco use and helping the public in Qatar and the Eastern Mediterranean region to quit all forms of tobacco use. HMC's Tobacco Control Centre, which has been a WHO Collaborating Centre since 2017, was selected as one of the award recipients in the Eastern Mediterranean region. This marks the second time the Centre has received the award, having first been honoured in 2021. The award was presented by Dr. Rayana Bou Haka, WHO representative in Qatar, in the presence of Dr. Ahmed Al Mohammed, HMC's deputy chief medical officer for medical services and chairman of the Department of Medicine. Dr Ahmad Mohamed Al Mulla, director of HMC's Tobacco Control Centre, expressed his pride in the Centre receiving the award for the second time. He praised the dedication of the Centre's team and the achievements in tobacco control in Qatar and the Eastern Mediterranean region. He said: 'HMC's Tobacco Control Centre has played a pioneering role in helping members of the public quit all forms of tobacco. This recognition by WHO reflects the positive outcomes of the hard work carried out by the Centre's team and its impact on many tobacco users in our community.' Dr. Rayana Bou Haka also commended the Centre's local and regional activities and said the award was well-deserved. She thanked the Centre's staff for their continued efforts in tobacco control in Qatar and the region and emphasised the importance of continued collaboration between the Centre and WHO, given the significant value of its tobacco control programs. The Tobacco Control Centre organizes educational and awareness initiatives targeting school and university students, as well as employees in ministries and public institutions. The Centre also delivers training programs for healthcare professionals and community organizations in Qatar and across the Eastern Mediterranean. In addition, it provides smoking cessation services and conducts research in the field of tobacco cessation. Dr Ahmad Al Mulla extended his gratitude to HMC leadership and the WHO Eastern Mediterranean Regional Office, represented by Dr Fatimah El Awa, WHO's Regional Advisor for the Tobacco Free Initiative, as well as the WHO Tobacco Free Initiative Office in Geneva, for their continuous support of the Centre's programs. He noted that this support contributes to the positive impact of the Centre's tobacco control activities at all levels in Qatar and the wider region. WHO annually recognizes individuals and institutions from each of its six regions on the occasion of World No Tobacco Day for their outstanding contributions to tobacco control. The recognition includes honorary awards, special certificates of appreciation from the WHO Director-General, and awards specifically related to World No Tobacco Day.
Qatar Tribune
14 hours ago
- Qatar Tribune
PM unveils MSDF Nat'l Strategy 2025-2030
QNA Doha Prime Minister and Minister of Foreign Affairs HE Sheikh Mohammed bin Abdulrahman bin Jassim Al Thani on Sunday launched the National Strategy 2025-2030 of the Ministry of Social Development and Family (MSDF), under the theme 'From Care to Empowerment.' The launch ceremony was attended by a number of ministers, senior officials, and representatives of government bodies and civil society institutions. On this occasion, the Minister of Social Development and Family HE Buthaina bint Ali Al Jabr Al Nuaimi said that the launch of the strategy represents a qualitative leap from a traditional care model to a more comprehensive, empowering, and sustainable approach based on a realistic understanding of the needs and challenges facing Qatari society. She noted that the strategy was the result of a collaborative effort involving various government entities, civil society institutions, and research centers. The strategy is built on five main pillars. The first focuses on strengthening the cohesion of Qatari families by developing preventive policies, parental education programs, and mental health initiatives to create a stable and adaptable family environment. The second pillar centers on empowering Qatari women and enhancing their participation across various sectors, particularly in leadership and decision-making positions. The strategy also prioritizes supporting vulnerable groups, particularly persons with disabilities, the elderly, widows, divorcees, and orphans by providing comprehensive social protection and services that foster their independence and integration into society. Another key focus is promoting a spirit of participation and solidarity by supporting civil society organizations, encouraging volunteerism, and ensuring the sustainability of charitable initiatives. The final pillar aims to improve the standard of living for individuals and families through economic empowerment, support for productive families, development of social services via digital transformation, and the enhancement of institutional capabilities and national partnerships.
